Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Surging Prevalence Of Chronic Disease
3.1.2. Advancements In Technology
3.1.3. Rising Approval Of Novel Oral Anticoagulants (Noacs)
3.2. Key Restraints
3.2.1. Side Effects Associated With Anticoagulants Treatment
3.2.2. High Price Of Noacs
3.2.3. Stringent Government Regulations

4. Key Analytics
4.1. Porter’S Five Forces Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’S Power
4.1.4. Supplier’S Power
4.1.5. Competitive Rivalry
4.2. Impact Of Covid-19 On Anticoagulants Market
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Key Investment Insights

5. Market By Application
5.1. Atrial Fibrillation & Heart Attack
5.2. Pulmonary Embolism (Pe)
5.3. Deep Vein Thrombosis (Dvt)
5.4. Stroke
5.5. Other Applications

6. Market By Route Of Administration
6.1. Oral Anticoagulants
6.2. Injectable Anticoagulants

7. Market By Drug Class
7.1. Noacs
7.2. Heparins & Low-Molecular-Weight Heparins (Lmwhs)
7.3. Vitamin K Antagonists
7.4. Other Drug Class

8. Geographical Analysis
8.1. North America
8.1.1. Market Size & Estimates
8.1.2. Key Growth Enablers
8.1.3. Key Challenges
8.1.4. Key Players
8.1.5. Country Analysis
8.1.5.1. United States
8.1.5.2. Canada

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Merger & Acquisitions
9.1.2. Product Launch & Developments
9.1.3. Partnership, Contract/Agreement & Collaboration
9.1.4. Business Expansion/ Approval/ Announcement
9.2. Company Profile
9.2.1. Abbott Laboratories
9.2.2. Alexion Pharmaceutical Inc
9.2.3. Aspen Pharmacare Holdings Limited
9.2.4. Bayer Ag
9.2.5. Boehringer Ingelheim Gmbh
9.2.6. Bristol-Myers Squibb Company
9.2.7. Daiichi Sankyo
9.2.8. Dr. Reddy’S Laboratories
9.2.9. Glaxosmithkline Plc
9.2.10. Johnson & Johnson
9.2.11. Leo Pharma As
9.2.12. Merck & Co
9.2.13. Novartis Ag
9.2.14. Pfizer Inc
9.2.15. Sanofi



List of Figures


Figure 1: Chronic Conditions In Patients Hospitalized With Covid-19 In The United States
Figure 2: Porter’S Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Key Investment Insights
Figure 6: North America Anticoagulants Market, By Application, In 2020
Figure 7: North America Anticoagulants Market, By Atrial Fibrillation & Heart Attack, 2021-2028 (In $ Million)
Figure 8: North America Anticoagulants Market, By Pulmonary Embolism (Pe), 2021-2028 (In $ Million)
Figure 9: North America Anticoagulants Market, By Deep Vein Thrombosis (Dvt), 2021-2028 (In $ Million)
Figure 10: North America Anticoagulants Market, By Stroke, 2021-2028 (In $ Million)
Figure 11: North America Anticoagulants Market, By Other Applications, 2021-2028 (In $ Million)
Figure 12: North America Anticoagulants Market, By Route Of Administration, In 2020
Figure 13: North America Anticoagulants Market, By Oral Anticoagulants, 2021-2028 (In $ Million)
Figure 14: North America Anticoagulants Market, By Injectable Anticoagulants, 2021-2028 (In $ Million)
Figure 15: North America Anticoagulants Market, By Drug Class, In 2020
Figure 16: North America Anticoagulants Market, By Noacs, 2021-2028 (In $ Million)
Figure 17: North America Anticoagulants Market, By Heparins & Low-Molecular-Weight Heparins (Lmwhs), 2021-2028 (In $ Million)
Figure 18: North America Anticoagulants Market, By Vitamin K Antagonists, 2021-2028 (In $ Million)
Figure 19: North America Anticoagulants Market, By Other Drug Class, 2021-2028 (In $ Million)
Figure 20: North America Anticoagulants Market, Country Outlook, 2020 & 2028 (In %)
Figure 21: The United States Anticoagulants Market, 2021-2028 (In $ Million)
Figure 22: Canada Anticoagulants Market, 2021-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - ANTICOAGULANTS
TABLE 2: NORTH AMERICA ANTICOAGULANTS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: NORTH AMERICA ANTICOAGULANTS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA ANTICOAGULANTS MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: NORTH AMERICA ANTICOAGULANTS MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA ANTICOAGULANTS MARKET, BY DRUG CLASS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: NORTH AMERICA ANTICOAGULANTS MARKET, BY DRUG CLASS, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA ANTICOAGULANTS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: NORTH AMERICA ANTICOAGULANTS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: LEADING PLAYERS OPERATING IN NORTH AMERICA ANTICOAGULANTS MARKET